# REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction

Study · id `cardio:ct-nct01381185` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01381185](<https://clinicaltrials.gov/study/NCT01381185>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01381185

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

## Technical summary

Registry record NCT01381185. Non-randomized; no masking; primary purpose diagnostic. Start 2011-05 (registry gives no type); primary completion 2015-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 154 participants (enrolled count; ClinicalTrials.gov record NCT01381185, source copy `cardio:ctgov-nct01381185-2016-10-27`, retrieved 2026-10-26)
- Start date: 2011-05 (registry gives no type) (ClinicalTrials.gov record NCT01381185, source copy `cardio:ctgov-nct01381185-2016-10-27`, retrieved 2026-10-26)
- Primary completion: 2015-06 (actual) (ClinicalTrials.gov record NCT01381185, source copy `cardio:ctgov-nct01381185-2016-10-27`, retrieved 2026-10-26)
- Completion: 2015-07 (actual) (ClinicalTrials.gov record NCT01381185, source copy `cardio:ctgov-nct01381185-2016-10-27`, retrieved 2026-10-26)
- Countries: Czechia (ClinicalTrials.gov record NCT01381185, source copy `cardio:ctgov-nct01381185-2016-10-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01381185-2016-10-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: REsistance to Aspirin and Clopidogrel in acuTe Myocardial Infarction
- Acronym: REACT-MI
- Condition: Acute Myocardial Infarction
- Intervention (Drug): Aspirin 200mg qd, Clopidogrel 2x75mg qd
- Lead sponsor: University Hospital Ostrava
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: University Hospital Ostrava (`cardio:org-university-hospital-ostrava`)

## Provenance

Content hash: c5e3c5149c6daea0533176168b3a4db9c3c05d4681ba08b7597a4b275bfc6567
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
